Literature DB >> 21834902

Nasu-Hakola disease with a splicing mutation of TREM2 in a Japanese family.

Y Numasawa1, C Yamaura, S Ishihara, S Shintani, M Yamazaki, H Tabunoki, J-I Satoh.   

Abstract

BACKGROUND: Nasu-Hakola disease (NHD) is a rare autosomal recessive disorder, characterized by a combination of progressive presenile dementia and formation of multifocal bone cysts, caused by genetic mutations of DAP12 and TREM2, which constitute a receptor/adapter signaling complex expressed on osteoclasts, dendritic cells, macrophages, and microglia. No Japanese patients with TREM2 mutations have been reported previously.
METHODS: We reported three siblings affected with NHD in a Japanese family. Amongst them, two died of NHD during the fourth decade of life. The analysis of genomic DNA, cDNA cloning, and western blot of lymphocyte proteins was performed on samples of the living patient. The transcriptome was studied in the autopsied brain of one patient.
RESULTS: We identified a homozygous conversion of a single nucleotide T to C at the second position of intron 3 in the splice-donor consensus site (c.482+2T>C) of the TREM2 gene, resulting in exon 3 skipping and aberrant expression of truncated proteins. We identified 136 upregulated genes involved in inflammatory response and immune cell trafficking and 188 downregulated genes including a battery of GABA receptor subunits and synaptic proteins in the patient's brain.
CONCLUSIONS: This is the first report of a Japanese NHD family caused by a splicing mutation of TREM2 that induces both neuroinflammation and neurodegeneration.
© 2010 The Author(s). European Journal of Neurology © 2010 EFNS.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21834902     DOI: 10.1111/j.1468-1331.2010.03311.x

Source DB:  PubMed          Journal:  Eur J Neurol        ISSN: 1351-5101            Impact factor:   6.089


  30 in total

1.  Cerebrospinal fluid soluble TREM2 is higher in Alzheimer disease and associated with mutation status.

Authors:  Laura Piccio; Yuetiva Deming; Jorge L Del-Águila; Laura Ghezzi; David M Holtzman; Anne M Fagan; Chiara Fenoglio; Daniela Galimberti; Barbara Borroni; Carlos Cruchaga
Journal:  Acta Neuropathol       Date:  2016-01-11       Impact factor: 17.088

2.  Variable expression of microglial DAP12 and TREM2 genes in Nasu-Hakola disease.

Authors:  Atsushi Sasaki; Akiyoshi Kakita; Kunihiro Yoshida; Takuya Konno; Takeshi Ikeuchi; Shintaro Hayashi; Hidenori Matsuo; Kei Shioda
Journal:  Neurogenetics       Date:  2015-05-23       Impact factor: 2.660

3.  Curcumin restores innate immune Alzheimer's disease risk gene expression to ameliorate Alzheimer pathogenesis.

Authors:  B Teter; T Morihara; G P Lim; T Chu; M R Jones; X Zuo; R M Paul; S A Frautschy; G M Cole
Journal:  Neurobiol Dis       Date:  2019-04-02       Impact factor: 5.996

Review 4.  The evolving biology of microglia in Alzheimer's disease.

Authors:  Tarja M Malm; Taylor R Jay; Gary E Landreth
Journal:  Neurotherapeutics       Date:  2015-01       Impact factor: 7.620

5.  A novel test for recessive contributions to complex diseases implicates Bardet-Biedl syndrome gene BBS10 in idiopathic type 2 diabetes and obesity.

Authors:  Elaine T Lim; Yangfan P Liu; Yingleong Chan; Tuomi Tiinamaija; AnnMari Käräjämäki; Erik Madsen; David M Altshuler; Soumya Raychaudhuri; Leif Groop; Jason Flannick; Joel N Hirschhorn; Nicholas Katsanis; Mark J Daly
Journal:  Am J Hum Genet       Date:  2014-10-16       Impact factor: 11.025

6.  Targeted sequencing approach to identify genetic mutations in Nasu-Hakola disease.

Authors:  Jun-Ichi Satoh; Motoaki Yanaizu; Youhei Tosaki; Kenji Sakai; Yoshihiro Kino
Journal:  Intractable Rare Dis Res       Date:  2016-11

7.  Expression of gp91phox and p22phox, catalytic subunits of NADPH oxidase, on microglia in Nasu-Hakola disease brains.

Authors:  Jun-Ichi Satoh; Yoshihiro Kino; Motoaki Yanaizu; Youhei Tosaki; Kenji Sakai; Tusyoshi Ishida; Yuko Saito
Journal:  Intractable Rare Dis Res       Date:  2016-11

8.  Gene expression profile of THP-1 monocytes following knockdown of DAP12, a causative gene for Nasu-Hakola disease.

Authors:  Jun-Ichi Satoh; Yoshihiro Shimamura; Hiroko Tabunoki
Journal:  Cell Mol Neurobiol       Date:  2011-11-12       Impact factor: 5.046

9.  Variants in triggering receptor expressed on myeloid cells 2 are associated with both behavioral variant frontotemporal lobar degeneration and Alzheimer's disease.

Authors:  Margarita Giraldo; Francisco Lopera; Ashley L Siniard; Jason J Corneveaux; Isabelle Schrauwen; Julian Carvajal; Claudia Muñoz; Manuel Ramirez-Restrepo; Chris Gaiteri; Amanda J Myers; Richard J Caselli; Kenneth S Kosik; Eric M Reiman; Matthew J Huentelman
Journal:  Neurobiol Aging       Date:  2013-04-09       Impact factor: 4.673

10.  TREM2 is associated with the risk of Alzheimer's disease in Spanish population.

Authors:  Bruno A Benitez; Breanna Cooper; Pau Pastor; Sheng-Chih Jin; Elena Lorenzo; Sebastian Cervantes; Carlos Cruchaga
Journal:  Neurobiol Aging       Date:  2013-02-05       Impact factor: 4.673

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.